Haemonetics | HAE - Selling And Administration Expenses

Stock Price
65.01
Daily Change
-0.77 -1.17%
Monthly
-20.83%
Yearly
-5.67%
Q1 Forecast
64.61

Haemonetics reported $101.62M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Avanos Medical USD 77.6M 5.9M Sep/2025
Baxter International USD 708M 10M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Boston Scientific USD 1.74B 25M Sep/2025
Cooper Companies USD 419.2M 12M Sep/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Haemonetics USD 101.62M 10.37M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
ICU Medical USD 152.77M 6.62M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
Masimo USD 116.4M 20.5M Sep/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
Quidel USD 186.9M 16.8M Sep/2025
ResMed USD 278.4M 19.2M Dec/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Steris USD 349.7M 4.1M Sep/2025
Stryker USD 2.14B 150M Dec/2025
Teleflex USD 281.76M 66.68M Sep/2025
Terumo JPY 97.88B 5.9B Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
US Physical Therapy USD 17.41M 62K Sep/2025
Zimmer Biomet Holdings USD 811.4M 3.4M Sep/2025